Glycolax and Pomalyst drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glycolax (polyethylene glycol 3350) and Pomalyst (pomalidomide). Common drug interactions include asthenia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Glycolax and Pomalyst. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Glycolax?

Glycolax has active ingredients of polyethylene glycol 3350. eHealthMe is studying from 2,036 Glycolax users. Check the latest studies of Glycolax.

What is Pomalyst?

Pomalyst has active ingredients of pomalidomide. eHealthMe is studying from 80,400 Pomalyst users. Check the latest studies of Pomalyst.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

20 people who take Glycolax and Pomalyst together, and have interactions are studied.

Glycolax and Pomalyst drug interactions.

What are the common drug interactions of Glycolax and Pomalyst, by gender? *:

female:

Asthenia (weakness)
Confusional state
Full blood count decreased
Urinary tract infection
Chest discomfort
Dyspnoea (difficult or laboured respiration)
Respiration (transport of oxygen from the outside air to the cells within tissues)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
Blood sodium decreased

male:

Anaemia (lack of blood)
Adverse drug reaction
Nausea (feeling of having an urge to vomit)
Plasma cell myeloma (cancer that begins in plasma cells)
Haematoma (collection of blood outside the blood vessels)
Vomiting
Drug intolerance (drug sensitivity)
Pneumonia
Tendon injury
Diarrhoea

What are the common drug interactions of Glycolax and Pomalyst, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Asthenia (weakness)
Confusional state
Anaemia (lack of blood)
Dizziness
Fall
Fatigue (feeling of tiredness)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Nausea (feeling of having an urge to vomit)
Full blood count decreased
Urinary tract infection

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 19 people, 95.00%
Pain: 1 person, 5.00%
Constipation: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Glycolax and Pomalyst?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously